Usher Institute, University of Edinburgh, Old Medical School, Teviot Place, Edinburgh, EH8 9AG, UK.
Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
Trials. 2023 Feb 21;24(1):127. doi: 10.1186/s13063-022-06959-6.
Enrolment is one of the most challenging aspects of conducting clinical trials, preceded by the process of informed consent (IC). Different strategies to improve recruitment in clinical trials have been used, including electronic IC. During COVID-19 pandemic, barriers to enrolment have been evident. Although digital technologies were acknowledged as the future of clinical research and potential advantages were shown for recruitment, electronic informed consent (e-IC) has not yet been globally adopted. The purpose of this review is to investigate the effect of using e-IC on enrolment, practical and economic benefits, challenges, and drawbacks when compared to traditional informed consent, through a systematic review.
Embase, Global Health Library, Medline, and The Cochrane Library databases were searched. No limit was set for publication date, age, sex, or study design. We included all studies within a randomized controlled trial (RCT), published in English, Chinese or Spanish, evaluating the electronic consent process used in the parent RCT. Studies were included if any of the three components ((i) information provision, (ii) participant's comprehension, (iii) signature) of the IC process was designed as electronic, whether administered remotely or face-to-face. The primary outcome was the rate of enrolment to the parent trial. Secondary outcomes were summarized according to the various findings reported on the use of electronic consent.
From a total of 9069 titles, 12 studies were included in the final analysis with a total of 8864 participants. Five studies of high heterogeneity and risk of bias showed mixed results on the efficacy of e-IC on enrolment. Data of included studies suggested e-IC could improve comprehension and recall of study-related information. Meta-analysis could not be conducted due to different study designs and outcome measures and the predominantly qualitative findings.
Few published studies have investigated the impact of e-IC on enrolment and findings were mixed. e-IC may improve participant's comprehension and recall of information. High-quality studies are needed to evaluate the potential benefit of e-IC to increase clinical trial enrolment.
PROSPERO CRD42021231035 . Registration date: 19-Feb-2021.
入组是开展临床试验最具挑战性的环节之一,在此之前是知情同意(IC)过程。为了提高临床试验的招募效果,已经采用了各种策略,包括电子知情同意(e-IC)。在 COVID-19 大流行期间,入组的障碍显而易见。虽然数字技术被认为是临床研究的未来,并显示出在招募方面的潜在优势,但电子知情同意(e-IC)尚未在全球范围内得到采用。本综述旨在通过系统评价研究比较传统知情同意时,调查使用电子知情同意对入组、实际和经济效益、挑战和缺点的影响。
检索了 Embase、全球卫生图书馆、Medline 和 Cochrane 图书馆数据库。未对发表日期、年龄、性别或研究设计设置限制。我们纳入了所有在随机对照试验(RCT)中发表的英文、中文或西班牙文研究,评估了用于父 RCT 的电子同意过程。如果知情同意过程的三个组成部分((i)信息提供,(ii)参与者的理解,(iii)签名)中的任何一个设计为电子,无论是远程还是面对面进行,研究均被纳入。主要结局是入组到父试验的比例。根据电子同意使用报告的各种发现,总结次要结局。
从总共 9069 个标题中,有 12 项研究最终纳入了总共 8864 名参与者的分析。五项高异质性和偏倚风险的研究显示,电子知情同意对入组效果的效果存在混合结果。纳入研究的数据表明,电子知情同意可以提高对研究相关信息的理解和记忆。由于不同的研究设计和结局指标以及主要是定性的发现,无法进行荟萃分析。
少数已发表的研究调查了电子知情同意对入组的影响,结果不一。电子知情同意可能会提高参与者对信息的理解和记忆。需要高质量的研究来评估电子知情同意增加临床试验入组的潜在益处。
PROSPERO CRD42021231035。注册日期:2021 年 2 月 19 日。